Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-042292)

Filing Details

Accession Number:: 0001140361-12-042292
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-02 15:15:16
Reporting Period:: 2012-09-27

Filing Date:: 2012-10-02
Accepted Time:: 2012-10-02 14:15:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1241031	R James Rusche	C/O Repligen Corporation 41 Seyon Street, Building 1, Suite 100 Waltham MA 02453	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-09-27	2,053	$5.90	157,068	No	4	S	Direct
Common Stock	Disposition	2012-09-27	1,138	$5.91	155,930	No	4	S	Direct
Common Stock	Disposition	2012-09-27	100	$5.92	155,830	No	4	S	Direct
Common Stock	Disposition	2012-09-27	476	$5.93	155,354	No	4	S	Direct
Common Stock	Disposition	2012-09-27	100	$6.00	155,254	No	4	S	Direct
Common Stock	Disposition	2012-09-27	1,133	$6.09	154,121	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The shares sold were previously held in a trust for Mr. Rusche's daughter.